• Admin Login
    View Item 
    •   Evidence@NottsHC Home
    • Conditions and diseases
    • Neurological conditions
    • Neurological conditions
    • View Item
    •   Evidence@NottsHC Home
    • Conditions and diseases
    • Neurological conditions
    • Neurological conditions
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Post-stroke fatigue: A scoping review

    Thumbnail
    Date
    2020
    Author
    Aali, Ghazaleh
    das Nair, Roshan
    Shokraneh, Farhad
    Metadata
    Show full item record
    Abstract
    Background: Post-stroke fatigue (PSF) is one of the most common and frustrating outcomes of stroke. It has a high prevalence and it can persist for many years after stroke. PSF itself contributes to a wider range of undesirable outcomes that affect all aspects of daily life. The aim of this review was to identify and summarise the most recent research on PSF, in order to update the evidence base. Methods: We updated an existing review (Hinkle et al. 2017) systematically searching CINAHL, MEDLINE, PsycINFO, and PubMed to cover new research studies between 1 st March 2016 and the search date (19 th January 2020). We included interventional and observational research, and clinical practice guidelines that were not covered in the original review. After duplicate removal in EndNote, two reviewers screened the search results in Rayyan, and data from eligible full texts were extracted onto an Excel spreadsheet. Finally, we used RobotReviewer and a human reviewer to assess the risk of bias of randomised trials for this scoping review. Results: We identified 45 records for 30 studies (14 observational, 10 interventional studies, and 6 guidelines). Apart from one, the interventional studies were single-centred, had high risk of bias and small sample size (median 50). They investigated exercise, pharmacotherapy, psychotherapy, education, and light therapy. Observational studies mainly reported the factors related to PSF including co-morbidities, depression and anxiety, quality of life, activities of daily living, stroke severity, medication use and polypharmacy, polymorphism, pain, apathy, limb heaviness, neuroticism, mobility, and thyroid-stimulating hormone. Guidelines either did not report on PSF or, when reported, their recommendations were supported by little or low level of evidence. Conclusion: Although we identified a number of recent studies which have added to our current knowledge on PSF, none are robust enough to change current clinical practice. © 2020 Aali G et al.
    URI
    https://repository.nottinghamshirehealthcare.nhs.uk/handle/123456789/3566
    https://f1000research.com/articles/9-242/v2
    Collections
    • Neurological conditions

    Copyright © Nottinghamshire Healthcare NHS Foundation Trust 2017
    Contact Us
    Powered by KnowledgeArc
     

     

    Browse

    All of Evidence@NottsHCCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    Researcher Directory

    Researchers

    Administration Area

    Admin Login

    Copyright © Nottinghamshire Healthcare NHS Foundation Trust 2017
    Contact Us
    Powered by KnowledgeArc